Rare Diseases: Shaping Biopharma’s Future from the Past
We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as…
“Rare Disease” Is More Than Just a Day
You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However,…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus.…
Survival in Uncertain Times
Like so many seasoned industry professionals, we eagerly seek thought leader perspectives — on the current biopharma…
Professionalism Still Matters
Sadly, another summer is coming to a close. If you have school-aged kids at home, you are undoubtedly already taking…
Be Bold, Be Empowered
Coming up the ranks in various roles, I remember feeling frustrated at times when leadership would not “decide” or…
Optimize Your Congress Planning
Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a…